International safety notice
Test LumiraDx SARS-CoV-2 Antígeno (Ag): Instrumento LumiraDx Platform. Referencia L001000305001 y Tiras Reactivas LumiraDx SARS-CoV-2 Antígeno (Ag). Referencia L016000101048.
Spain / AEMPS · ESP · Mar 2, 2021
Key facts
| Title | Test LumiraDx SARS-CoV-2 Antígeno (Ag): Instrumento LumiraDx Platform. Referencia L001000305001 y Tiras Reactivas LumiraDx SARS-CoV-2 Antígeno (Ag). Referencia L016000101048. |
|---|---|
| Regulator | Spain / AEMPS |
| Country | ESP |
| Brand | Test LumiraDx SARS-CoV-2 Antígeno (Ag): Instrumento LumiraDx Platform. Referencia L001000305001 y Tiras Reactivas LumiraDx SARS-CoV-2 Antígeno (Ag). Referencia L016000101048. |
| Manufacturer | LumiraDx UK Ltd, Reino Unido |
| Models | 18-MAY-21, 6000091, 21-FEB-21, _19027, 25-APR-21, _23384, 5000238, GM2000155, L016000101048, 28-FEB-21, 14-FEB-21, 24-FEB-21 and 91 more |
| Event type | Safety Notice |
| Date | Mar 2, 2021 |
At a glance
- No Recall
- Yes Field safety notice
- 1–9 Matching device models in FDA data
- 1–9 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1